Advertisement

Topics

Novo gets US backing for Victoza cardiovascular data

02:42 EDT 21 Jun 2017 | PharmaTimes

US regulatory advisors are backing the claim that Novo Nordisks’ Victoza reduces cardiovascular risk in patients with diabetes.

Original Article: Novo gets US backing for Victoza cardiovascular data

NEXT ARTICLE

More From BioPortfolio on "Novo gets US backing for Victoza cardiovascular data"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...